// App-Quantinova.ai

3646 : Thrombin Generation Measurement In Whole Blood As a Control For Vitamin K Antagonist Treatment - Effect Of Thrombomodulin

Researchers

Presenter

  • Saartje Bloemen

Principal Investigators

  • Marieke de Laat

  • Arina ten Cate-Hoek

  • Hugo ten Cate

  • Bas De Laat

  • H. Coenraad Hemker

  • Raed Al Dieri

Medical Centers

  • Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, Netherlands

  • Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, Netherlands

  • Synapse BV, CARIM, Maastricht University, Maastricht, Netherlands

  • Department of Gastroenterology, Atrium Medical Center, Heerlen, Netherlands

  • Department of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands

  • Synapse BV, CARIM, Maastricht University, Maastricht, Netherlands

  • Department of Biochemistry, CARIM, Maastricht University, Maastricht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • Catalase

Drug/Treatment

  • Thrombomodulin alfa

  • Protein C

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim